A research team has uncovered the mechanism and underlying reason behind the transformation of residual cells into epidermal ...

For decades, scientists assumed that neural stem cells (NSCs) only occur in the brain and spinal cord. A new international ...

Drug-carrying DNA aptamers can deliver a one-two punch to leukemia by precisely targeting the elusive cancer stem cells that seed cancer relapses, researchers report. The aptamers -- short ...

A new review has found a lack of convincing evidence stem cell injections are helpful for knee osteoarthritis. But there are ...

The interplay between aging and cellular senescence reveals insights into chronic inflammation and potential strategies for enhancing healthspan and longevity.

However, other trends, such as the increased use of donor PBSCs as a source of stem cells, extending alloSCT to older/sicker patients and the use of alternative donors (haploidentical and HLA ...

PARIS, France I March 20, 2025 I Sanofi and Dren Bio, Inc., a private clinical-stage biopharmaceutical company, have entered into a definitive agreement under which Sanofi has agreed to acquire ...

Dren Bio deep B-cell depleter program has the potential to reset the immune system Acquisition underpins path for Sanofi becoming leading immunology company Sanofi to pay $600 million up front Paris, ...

Sanofi to acquire Dren Bio’s bispecific myeloid cell engager for deep B-cell depletion, broadening immunology pipeline Dren Bio deep B-cell depleter program has the potential to reset the immune ...